La dysarthrie dans la maladie de Parkinson
暂无分享,去创建一个
[1] C. Coelho,et al. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states. , 2002, Journal of communication disorders.
[2] Lise Crevier-Buchman,et al. Les troubles de la parole et de la déglutition dans la maladie de Parkinson , 2000 .
[3] Bernard Teston,et al. La dysprosodie parkinsonienne , 2005 .
[4] K. Tjaden,et al. An acoustic study of coarticulation in dysarthric speakers with Parkinson disease. , 2000, Journal of speech, language, and hearing research : JSLHR.
[5] B Pentland,et al. Impressions of parkinsonian patients from their recorded voices. , 1990, The British journal of disorders of communication.
[6] A. Aronson,et al. Clusters of deviant speech dimensions in the dysarthrias. , 1969, Journal of speech and hearing research.
[7] Daniel Kempler,et al. Effect of Speech Task on Intelligibility in Dysarthria: A Case Study of Parkinson's Disease , 2002, Brain and Language.
[8] K. Yorkston,et al. Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria. , 1996, Journal of communication disorders.
[9] I Litvan,et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. , 2001, Archives of neurology.
[10] H. Yilmaz,et al. Voice analysis and videolaryngostroboscopy in patients with Parkinson's disease , 2002, European Archives of Oto-Rhino-Laryngology.
[11] J. Peragut,et al. Effects of Pharmacological versus Electrophysiological Treatments on Parkinsonian Dysprosody , 2002 .
[12] M. Gentil,et al. The Effect of Levodopa on Vocal Function in Parkinson's Disease , 2001, Clinical neuropharmacology.
[13] G. Canter. SPEECH CHARACTERISTICS OF PATIENTS WITH PARKINSON'S DISEASE: I. INTENSITY, PITCH, AND DURATION. , 1963, The Journal of speech and hearing disorders.
[14] E. Metter,et al. Clinical and acoustical variability in hypokinetic dysarthria. , 1986, Journal of communication disorders.
[15] H. Teulings,et al. Handwriting and speech changes across the levodopa cycle in Parkinson's disease. , 1998, Acta psychologica.
[16] M. Hirano. Objective evaluation of the human voice: clinical aspects. , 1989, Folia phoniatrica.
[17] R. Iansek,et al. Speech impairment in a large sample of patients with Parkinson's disease. , 1998, Behavioural neurology.
[18] A. Aronson,et al. Differential diagnostic patterns of dysarthria. , 1969, Journal of speech and hearing research.
[19] B. Teston,et al. Effets de la L-DOPA sur la dysprosodie et le fonctionnement laryngien de patients parkinsoniens , 2004 .
[20] J. Logemann,et al. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. , 1978, The Journal of speech and hearing disorders.
[21] P. Snyder,et al. Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: A longitudinal case study , 2004, Brain and Cognition.
[22] R Iansek,et al. Regulation of parkinsonian speech volume: the effect of interlocuter distance , 1999, Journal of neurology, neurosurgery, and psychiatry.
[23] L. Hartelius,et al. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey. , 1994, Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics.
[24] A. Aronson,et al. Motor Speech Disorders , 2014 .
[25] Raymond D. Kent,et al. Prosodic disturbance and neurologic lesion , 1982, Brain and Language.
[26] E. Lin,et al. Glottographic Measures Before and After Levodopa Treatment in Parkinson's Disease , 1999, The Laryngoscope.
[27] Raymond D. Kent,et al. What dysarthrias can tell us about the neural control of speech , 2000, J. Phonetics.